A promising platform for predicting toxicity

by Maria Ochoa de Olza
Published 2021-09-01

Tumor-Associated Microbiome: Where Do We Stand?

by Marc Oliva, Nuria Mulet-Margalef, Maria Ochoa-De-Olza, Stefania Napoli, Joan Mas, Berta Laquente, Laia Alemany, Eric J. Duell, Paolo Nuciforo, Victor Moreno
Published 2021-02-01

Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes

by Alexandre Harari, Stefan Zimmermann, Maria Ochoa de Olza, Angela Orcurto, Andreas Hottinger, Benita Wolf, Blanca Navarro Rodrigo, Aymeric Auger, Virginie Zimmer, Philippe Gannon, Lana Kandalaft, Lionel Trueb
Published 2020-07-01

A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors

by Jennifer Mataraza, Todd M Bauer, Justin F Gainor, Sunil Sharma, Maria Ochoa de Olza, Jan H M Schellens, Hongqian Wu, Haiying Sun, Antonio P Silva, Jason Faris, Scott Cameron
Published 2020-06-01

Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients

by Gabriela Jiménez-Valerio, Mar Martínez-Lozano, Nicklas Bassani, August Vidal, María Ochoa-de-Olza, Cristina Suárez, Xavier García-del-Muro, Joan Carles, Francesc Viñals, Mariona Graupera, Stefano Indraccolo, Oriol Casanovas
Published 2016-05-01

Frequency and characteristics of familial melanoma in Spain: the FAM-GEM-1 Study.

by Iván Márquez-Rodas, Manuel Martín González, Eduardo Nagore, Cristina Gómez-Fernández, Jose Antonio Avilés-Izquierdo, Cayetana Maldonado-Seral, Virtudes Soriano, Margarita Majem-Tarruella, Virginia Palomar, Rocio Maseda, Alfonso Martín-Carnicero, Teresa Puertolas, Elena Godoy, Pablo Cerezuela, Maria Ochoa de Olza, Begoña Campos, Elisabeth Perez-Ruiz, Ainara Soria, Irene Gil-Arnaiz, Maria Gonzalez-Cao, Elisa Galvez, Ana Arance, Joaquin Belon, Luis de la Cruz-Merino, Salvador Martín-Algarra, Spanish Multidisciplinary Group of Melanoma (GEM)
Published 2015-01-01